Bank Hapoalim BM’s Compugen CGEN Stock Holding History

Bank Hapoalim BM’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,000	Closed	-$51K	–	118
2026 Q1	$51K	Hold	24,000	–	–	0.01%	112
2025 Q4	$37K	Buy	+24,000	New	+$39.9K	﹤0.01%	110

Other funds holding CGEN

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

Eagle Rock Investment Company Atlanta, Georgia $808M AUM 44.28% 1-Year Est. Return

EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

Schnieders Capital Management Pasadena, California $762M AUM 34.09% 1-Year Est. Return

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

Bank Hapoalim BM's CGEN Position: Q2 2026 in Review

Bank Hapoalim BM sold out of Compugen (CGEN) in Q2 2026, closing a stake of 24,000 shares — an estimated $51K sold.

Bank Hapoalim BM first reported a position in CGEN in Q4 2025 and held it in 2 quarters. The position peaked at $51K in Q1 2026. 27 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

Bank Hapoalim BM reported no remaining Compugen position as of Q2 2026 after selling out during the quarter.
Bank Hapoalim BM sold 24,000 Compugen shares in Q2 2026, an estimated $51K.
Bank Hapoalim BM first reported a position in Compugen in Q4 2025 and held it in 2 quarters.
Bank Hapoalim BM's Compugen position peaked at $51K in Q1 2026.
27 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on Bank Hapoalim BM's 13F filing for Q2 2026, filed 5 Aug 2026.